Buqué Martinez, Aitziber

Publications

Sort by

Co-Author Network

selected publications

Preface. Methods in cell biology. 2024 Editorial Article GET IT
Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium. Cancer immunology research. 2023 Academic Article GET IT
BCL2 inhibition reveals a dendritic cell-specific immune checkpoint that controls tumor immunosurveillance. Cancer discovery. 2023 Academic Article GET IT
Flow cytometry-assisted quantification of cell cycle arrest in cancer cells treated with CDK4/6 inhibitors. Methods in cell biology. 2023 Academic Article GET IT
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies. Journal for immunotherapy of cancer. 2023 Academic Article GET IT
Cellular senescence in the response of HR⁺ breast cancer to radiotherapy and CDK4/6 inhibitors. Journal of translational medicine. 2023 Academic Article GET IT
Quantitative assessment of mitophagy in irradiated cancer cells. Methods in cell biology. 2022 Academic Article GET IT
PDIA3 epitope-driven immune autoreactivity contributes to hepatic damage in type 2 diabetes. Science immunology. 2022 Academic Article GET IT
Quantification of cytosolic DNA species by immunofluorescence microscopy and automated image analysis. 2022 GET IT
RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells. 2022 GET IT
Cytofluorometric assessment of acute cell death responses driven by radiation therapy. 2022 GET IT
Nicotinamide drives T cell activation in the mammary tumor microenvironment. Journal of translational medicine. 2022 Letter GET IT
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment. Nature reviews. Drug discovery. 2022 Review GET IT
Cytofluorometric assessment of cell cycle progression in irradiated cells. 2022 GET IT
Emergent impact of lifestyle on tumor progression and response to therapy. International review of cell and molecular biology. 2022 Editorial Article GET IT
LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. Oncoimmunology. 2021 Academic Article GET IT
Targeting Serine in Cancer: Is Two Better Than One?. Trends in cancer. 2021 Article GET IT
Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells. STAR protocols. 2021 Academic Article GET IT
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER⁺ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Academic Article GET IT
Times cited: 41
Preface: Chemical carcinogenesis in mice as a model of human cancer: Pros and cons. Methods in cell biology. 2021 Editorial Article GET IT
Immunomodulation by targeted anticancer agents. Cancer cell. 2020 Information Resource GET IT
Times cited: 14
MPA/DMBA-driven mammary carcinomas. Methods in cell biology. 2020 Article GET IT
Times cited: 1
NK cells beat T cells at early breast cancer control. Oncoimmunology. 2020 Editorial Article GET IT
Times cited: 11
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nature reviews. Clinical oncology. 2020 Information Resource GET IT
Times cited: 81
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nature immunology. 2020 Academic Article GET IT
Times cited: 48
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature communications. 2020 Academic Article GET IT
Times cited: 74
Possible mechanisms of cancer prevention by nicotinamide. British journal of pharmacology. 2020 Information Resource GET IT
Times cited: 3
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal for immunotherapy of cancer. 2020 Information Resource GET IT
Times cited: 619
PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models. Oncoimmunology. 2020 Academic Article GET IT
Times cited: 78
Methods to Detect Immunogenic Cell Death In Vivo. Methods in molecular biology (Clifton, N.J.). 2020 Article GET IT
Times cited: 3
Preface-Autophagy: An old mechanism with new challenges ahead. Progress in molecular biology and translational science. 2020 Editorial Article GET IT
Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients. Oncoimmunology. 2019 Academic Article GET IT
Times cited: 99
Apoptotic caspases cut down the immunogenicity of radiation. Oncoimmunology. 2019 Academic Article GET IT
Times cited: 23
Monitoring abscopal responses to radiation in mice. Methods in enzymology. 2019 Article GET IT
Anticancer effects of anti-CD47 immunotherapy in vivo. Oncoimmunology. 2018 Academic Article GET IT
Times cited: 30
Modeling Tumor Immunology and Immunotherapy in Mice. Trends in cancer. 2018 Article GET IT
Times cited: 33
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. Oncoimmunology. 2018 Information Resource GET IT
Times cited: 34
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance. Immunological reviews. 2017 Information Resource GET IT
Times cited: 47
Reply: The complement system is also important in immunogenic cell death. Nature reviews. Immunology. 2016 Article GET IT
Times cited: 5
Immunogenic cell death in cancer and infectious disease. Nature reviews. Immunology. 2016 Information Resource GET IT
Times cited: 987
The ratio of CD8⁺/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ. Oncoimmunology. 2016 Academic Article GET IT
Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 2016 Information Resource GET IT
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer cell. 2016 Academic Article GET IT
Times cited: 383
Prevention of breast cancer by RANKL/RANK blockade. Cell research. 2016 Article GET IT
Times cited: 5
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology. 2016 Information Resource GET IT
Times cited: 49
Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer. Oncoimmunology. 2016 Academic Article GET IT
Times cited: 19
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer cell. 2015 Information Resource GET IT
Times cited: 721
Trial Watch-Immunostimulation with cytokines in cancer therapy. Oncoimmunology. 2015 Information Resource GET IT
Trial Watch-Oncolytic viruses and cancer therapy. Oncoimmunology. 2015 Information Resource GET IT
Morphometric analysis of immunoselection against hyperploid cancer cells. Oncotarget. 2015 Academic Article GET IT
Times cited: 11
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. Oncoimmunology. 2015 Information Resource GET IT
Trial Watch: Adoptive cell transfer for oncological indications. Oncoimmunology. 2015 Information Resource GET IT
Trial watch: Naked and vectored DNA-based anticancer vaccines. Oncoimmunology. 2015 Academic Article GET IT
eIF2α phosphorylation as a biomarker of immunogenic cell death. Seminars in cancer biology. 2015 Information Resource GET IT
Times cited: 69
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology. 2015 Information Resource GET IT
Trial Watch: Peptide-based anticancer vaccines. Oncoimmunology. 2015 Information Resource GET IT
Classification of current anticancer immunotherapies. Oncotarget. 2014 Review GET IT
Times cited: 368
Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 2014 Information Resource GET IT

more ...

less ...

Background

education and training

Ph.D., University of the Basque Country (Spain) 2013
M.Sc., University of the Basque Country (Spain) 2010
M.Sc., Autonomous University of Madrid (Spain) 2006
B.S., University of the Basque Country (Spain) 2004

Contact

full name

Aitziber Buqué Martinez

primary email

abm2013@med.cornell.edu

VIVO Weill Cornell Medical College

Aitziber Buqué Martinez Instructor of Cell Biology in Radiation Oncology

Publications

selected publications

Background

education and training

Contact

full name

primary email